Tetraphase Pharmaceuticals

Tetraphase Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing novel antibiotics to treat the serious and life-threatening multidrug-resistant infections that pose a major and growing global health threat. Tetraphase’s proprietary breakthrough chemistry technology enables the design of molecules that can overcome antibiotic resistance. Our drug platform has led to the creation of more than 3,000 broad- and selective-spectrum antibiotic drug candidates. Tetraphase common stock trades under the NASDAQ symbol ‘TTPH.’ Tetraphase is well positioned to be a major player in the multidrug-resistant arena.
Type
Public
HQ
Watertown, US
Founded
2006
Employees
69 (est)+26%
Tetraphase Pharmaceuticals was founded in 2006 and is headquartered in Watertown, US

Key People at Tetraphase Pharmaceuticals

Patrick Gage

Patrick Gage

Chairman

Tetraphase Pharmaceuticals Locations

Watertown, US

Tetraphase Pharmaceuticals Metrics

Tetraphase Pharmaceuticals Summary

Market capitalization

$170 M

Closing share price

$4.62
Tetraphase Pharmaceuticals's latest market capitalization is $170 M.

Tetraphase Pharmaceuticals Market Value History

6% of current employees of Tetraphase Pharmaceuticals are female and 94% are male.

Tetraphase Pharmaceuticals News

Tetraphase Pharmaceuticals Company Life

You may also be interested in